Skip to main content
. 2007 Sep 6;6:122. doi: 10.1186/1475-2875-6-122

Table 2.

Secondary parameters to be included in WARN Pharmacokinetic Database, if available.

Patient characteristics Antimalarial Methodology Pharmacokinetic parameters
Height Directly Observed Therapy (DOT) [1] Method for separating free drug Primary parameters: Absorption rate constant (Ka); Elimination Rate constant (Ke), Volume of distribution; Clearance rate.
Vomiting Batch number & Expiry Date Sample handling Secondary parameters: Cmax, tmax, elimination half-life;
Diarrhoea Method of Administration [2] Total vs free drug
Baseline parasite density Co-administration [3] Metabolites
Haematocrit, Bilirubin, Creatinine, Albumin (alpha1 glycoprotein, lipoprotein)
Ethnicity

Footnotes to Table 2

DOT: All doses supervised; First dose supervised; Unsupervised.

2. Administration: Whole tablets; Divided tablets; Crushed tablets.

3. Co-administration: Water; Fat content; Sugar water; Concomitant medication